Sarah Haney, MD
Family Practice · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Office
- 1
Offices
1 location · One Medical Group Inc · 330 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Haney’s office at (650) 288-4080 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A175800 · Current
Licensed to practise in California · since 2021 · expires 2027-12-31 · University of Washington School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$12,197
Medicare paid this office $12,197 for 57 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 32 | $5,187 | $100 |
| Short return visit (20+ min) | 29 | $3,447 | $72 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 14 | $344 | $14 |
| Insertion of needle into vein for collection of blood sample | 18 | $173 | $9 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
57 Original Medicare patients in 2024. Average age 72 · Women 61% · Health risk score 0.74. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 53%.
The office billed $83,668, Medicare allowed $17,183 and paid $12,197; for 173 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 57 | 173 | 72 | 0.74 | $83,668 | $12,197 |
| 2023 | 58 | 181 | 73 | 0.70 | $99,291 | $15,696 |
| 2022 | 17 | 37 | 74 | 0.65 | $16,640 | $2,853 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 31 | $5,958 | $115 |
| Short return visit (20+ min) | 27 | $3,632 | $77 |
| Insertion of needle into vein for collection of blood sample | 22 | $202 | $8 |
2022: 1 service
| Short return visit (20+ min) | 13 | $1,567 | $82 |
Medicaid work
$8,277 in 2021
Medicaid paid $8,277 for 923 billed services this clinician did in 2021, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 877 | $7,257 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 46 | $1,020 |
| 2021 | 923 | 2 | 21 | $8,277 |
Drugs they prescribed that Part D paid
$19,939
Pharmacies billed $19,939 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
296 generic and 39 brand-name prescriptions · $19,939 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Adderall Xr | 14 | $3,387 | $242 |
| Atorvastatin | 25 | $611 | $24 |
| Pregabalin | 18 | $502 | $28 |
| Losartan | 14 | $152 | $11 |
| Metformin | 14 | $137 | $10 |
See all 8 drugs
| Adderall Xr | 14 | $3,387 | $242 |
| Atorvastatin | 25 | $611 | $24 |
| Pregabalin | 18 | $502 | $28 |
| Losartan | 14 | $152 | $11 |
| Metformin | 14 | $137 | $10 |
| Hydrochlorothiazide | 12 | $101 | $8 |
| Lisinopril | 15 | $26 | $2 |
| Amlodipine Besylate | 13 | $23 | $2 |
Year by year
| 2024 | 335 | 53 | None | 12% | $19,939 |
| 2023 | 252 | 44 | None | 19% | $22,589 |
| 2022 | 53 | 14 | 0% (0) | None | $4,176 |
| 2021 | 96 | 19 | 0% (0) | 23% | $11,138 |
| 2020 | 766 | 109 | None | 17% | $77,307 |
| 2019 | 1,026 | 131 | 0% (0) | 19% | $117,184 |
| 2018 | 866 | 97 | 0% (0) | 18% | $87,084 |
| 2017 | 197 | 47 | 0% (0) | 19% | $10,468 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Adderall Xr | 18 | $4,300 | $239 |
| Atorvastatin | 15 | $207 | $14 |
| Losartan | 12 | $168 | $14 |
2021: 2 drugs
| Alcohol Pads | 11 | $597 | $54 |
| Metformin | 11 | $30 | $3 |
2020: 20 drugs
| Flovent Hfa | 13 | $4,005 | $308 |
| Gabapentin | 58 | $1,495 | $26 |
| Ziprasidone | 23 | $1,107 | $48 |
| Pantoprazole | 17 | $687 | $40 |
| Fluoxetine | 15 | $381 | $25 |
| Omeprazole | 24 | $356 | $15 |
| Baclofen | 14 | $320 | $23 |
| Atorvastatin | 29 | $304 | $10 |
| Buspirone | 17 | $294 | $17 |
| Levothyroxine | 15 | $288 | $19 |
| Olanzapine | 12 | $231 | $19 |
| Venlafaxine Hcl Er | 13 | $223 | $17 |
| Losartan | 19 | $139 | $7 |
| Lisinopril | 28 | $126 | $4 |
| Metformin | 16 | $120 | $8 |
| Metformin Hcl Er | 20 | $104 | $5 |
| Hydrochlorothiazide | 11 | $95 | $9 |
| Amlodipine Besylate | 18 | $84 | $5 |
| Meloxicam | 11 | $71 | $6 |
| Furosemide | 14 | $67 | $5 |
2019: 24 drugs
| Flovent Hfa | 18 | $5,719 | $318 |
| Gabapentin | 60 | $1,427 | $24 |
| Nystatin | 16 | $1,024 | $64 |
| Levothyroxine | 54 | $793 | $15 |
| Pravastatin | 17 | $767 | $45 |
| Atorvastatin | 45 | $759 | $17 |
| Omeprazole | 33 | $748 | $23 |
| Pantoprazole | 17 | $472 | $28 |
| Lisinopril | 67 | $436 | $7 |
| Hydroxyzine | 24 | $412 | $17 |
| Escitalopram | 15 | $314 | $21 |
| Metformin Hcl Er | 26 | $275 | $11 |
| Losartan | 32 | $266 | $8 |
| Baclofen | 13 | $262 | $20 |
| Acetic Acid | 14 | $218 | $16 |
| Metformin | 20 | $190 | $10 |
| Risperidone | 14 | $171 | $12 |
| Naproxen | 14 | $164 | $12 |
| Sertraline | 15 | $151 | $10 |
| Meloxicam | 19 | $125 | $7 |
| Promethazine | 13 | $114 | $9 |
| Hydrochlorothiazide | 24 | $98 | $4 |
| Amlodipine Besylate | 18 | $95 | $5 |
| Jantoven | 11 | $43 | $4 |
2018: 22 drugs
| Incruse Ellipta | 19 | $6,249 | $329 |
| Proair Hfa | 20 | $1,526 | $76 |
| Atorvastatin | 37 | $767 | $21 |
| Levothyroxine | 35 | $734 | $21 |
| Gabapentin | 28 | $623 | $22 |
| Bupropion Hcl Sr | 12 | $547 | $46 |
| Omeprazole | 36 | $543 | $15 |
| Quetiapine | 16 | $495 | $31 |
| Divalproex Sodium Er | 13 | $442 | $34 |
| Potassium Chloride | 12 | $311 | $26 |
| Metformin Hcl Er | 17 | $302 | $18 |
| Lisinopril | 43 | $289 | $7 |
| Sertraline | 19 | $229 | $12 |
| Amlodipine Besylate | 24 | $213 | $9 |
| Metformin | 15 | $204 | $14 |
| Simvastatin | 11 | $184 | $17 |
| Losartan | 21 | $170 | $8 |
| Furosemide | 32 | $162 | $5 |
| Cartia Xt | 11 | $121 | $11 |
| Meloxicam | 24 | $103 | $4 |
| Jantoven | 15 | $97 | $6 |
| Hydrochlorothiazide | 19 | $88 | $5 |
2017: 3 drugs
| Levothyroxine | 12 | $214 | $18 |
| Atorvastatin | 11 | $178 | $16 |
| Omeprazole | 11 | $111 | $10 |
Money from drug and device companies
$60 in 2021
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Gardasil 9 | $44 | 2 payments
|
| GlaxoSmithKline | Shingrix | $16 | 1 payment
|
See all 3 published payments
| Merck Sharp & Dohme | Meals · 2021-09-14 | Gardasil 9 | $23 |
| Merck Sharp & Dohme | Meals · 2021-04-14 | Gardasil 9 | $20 |
| GlaxoSmithKline | Meals · 2021-02-25 | Shingrix | $16 |
Professional record
- NPI
- 1003285420
- Licence
- CA A175800California A175800: Current · expires 2027-12-31
- Trained
- University of Washington School of Medicine, 2017
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2015-09-15
- NPI last updated
- 2025-03-17
- NPI record certified
- 2025-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 100 E 33rd St, Vancouver, WA, 98663